JP2021519330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021519330A5 JP2021519330A5 JP2020552400A JP2020552400A JP2021519330A5 JP 2021519330 A5 JP2021519330 A5 JP 2021519330A5 JP 2020552400 A JP2020552400 A JP 2020552400A JP 2020552400 A JP2020552400 A JP 2020552400A JP 2021519330 A5 JP2021519330 A5 JP 2021519330A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- mumefural
- composition according
- active ingredient
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FYDIRKLRXHXXHY-UHFFFAOYSA-N Mumefural Chemical compound OC(=O)CC(O)(C(O)=O)CC(=O)OCC1=CC=C(C=O)O1 FYDIRKLRXHXXHY-UHFFFAOYSA-N 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 4
- 208000010877 cognitive disease Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 208000028698 Cognitive impairment Diseases 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 2
- 235000013376 functional food Nutrition 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 201000004810 Vascular dementia Diseases 0.000 claims 1
- 230000003920 cognitive function Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010027175 memory impairment Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2018-0035324 | 2018-03-27 | ||
| KR1020180035324A KR102037944B1 (ko) | 2018-03-27 | 2018-03-27 | 무메푸랄을 포함하는 인지장애 관련 질환의 예방 또는 치료용 조성물 |
| PCT/KR2019/002545 WO2019190069A1 (ko) | 2018-03-27 | 2019-03-05 | 무메푸랄을 포함하는 인지장애 관련 질환의 예방 또는 치료용 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519330A JP2021519330A (ja) | 2021-08-10 |
| JP2021519330A5 true JP2021519330A5 (enExample) | 2021-09-16 |
Family
ID=68062313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552400A Pending JP2021519330A (ja) | 2018-03-27 | 2019-03-05 | ムメフラールを含む認知障害関連疾患の予防又は治療用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210106550A1 (enExample) |
| EP (1) | EP3789023A4 (enExample) |
| JP (1) | JP2021519330A (enExample) |
| KR (1) | KR102037944B1 (enExample) |
| AU (1) | AU2019241803A1 (enExample) |
| WO (1) | WO2019190069A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102301757B1 (ko) | 2020-12-18 | 2021-09-13 | 서울대학교산학협력단 | 스트레스로 인한 기억력 감퇴 억제 및 학습 능력 향상을 위한 천연 혼합 조성물 |
| CN115531368A (zh) * | 2021-06-14 | 2022-12-30 | 谭文 | R-氨基甲酸酯-β-苯乙醇胺类化合物治疗学习和记忆缺陷以及神经退行性疾病的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100525474B1 (ko) * | 2003-10-07 | 2005-11-02 | 롯데제과주식회사 | 항스트레스 및 뇌기능 개선 효과를 가지는 가미사군자탕 함유 의약품 |
| JP2005289940A (ja) * | 2004-04-05 | 2005-10-20 | Hiroko Ito | フリーラジカル消去剤 |
| RU2327480C1 (ru) * | 2007-05-23 | 2008-06-27 | Виктор Иванович Рощин | Активный ингредиент лекарственного средства, лекарственное средство, фармацевтическая композиция и способ лечения больных с дементным синдромом |
| KR101144197B1 (ko) * | 2009-03-31 | 2012-05-11 | 전남대학교산학협력단 | 신생혈관형성 억제제 및 이를 이용한 천연산물 항비만제 |
| CN103237556B (zh) * | 2010-10-04 | 2016-03-16 | 韩国韩医学研究院 | 包含乌梅提取物的用于预防或治疗痴呆的组合物 |
| KR20140144785A (ko) | 2013-06-11 | 2014-12-22 | 한국식품연구원 | 유자(Citrus junos Tanaka) 추출물을 유효성분으로 포함하는 기억력 및 학습 능력 증진용 조성물 |
| KR101823892B1 (ko) | 2014-03-10 | 2018-02-01 | 우석대학교 산학협력단 | 기억력 개선, 인지능력 개선, 치매 예방, 지연 또는 치료 효과를 나타내는 봉선화 추출물, 이를 유효성분으로 하는 약제학적 조성물, 이를 유효성분으로 포함하는 기능성 건강보조식품 및 봉선화 추출물의 제조방법 |
| KR101837444B1 (ko) | 2016-10-25 | 2018-03-13 | 한국 한의학 연구원 | 양지꽃 추출물을 유효성분으로 함유하는 인지기능 장애의 예방, 개선 또는 치료용 조성물 |
-
2018
- 2018-03-27 KR KR1020180035324A patent/KR102037944B1/ko active Active
-
2019
- 2019-03-05 EP EP19774894.0A patent/EP3789023A4/en not_active Withdrawn
- 2019-03-05 AU AU2019241803A patent/AU2019241803A1/en not_active Abandoned
- 2019-03-05 JP JP2020552400A patent/JP2021519330A/ja active Pending
- 2019-03-05 US US17/041,840 patent/US20210106550A1/en not_active Abandoned
- 2019-03-05 WO PCT/KR2019/002545 patent/WO2019190069A1/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016512531A5 (enExample) | ||
| JP6595078B2 (ja) | アミノカルボニルカルバメート化合物 | |
| JP2018035160A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| MX2020012827A (es) | Compuestos tetrahidro-1h-pirazino[2,1-a]isoindolilquinolina para el tratamiento de enfermedades autoinmunes. | |
| CN114901656A (zh) | 羟肟酸酯化合物、其制备方法及其应用 | |
| JP2019535723A5 (enExample) | ||
| MX2022006470A (es) | Tiromimeticos novedosos. | |
| RU2019135261A (ru) | Фармацевтическая композиция, содержащая ингибитор pde9 | |
| JP2021519330A5 (enExample) | ||
| JP2021503483A5 (enExample) | ||
| JP2019151627A5 (enExample) | ||
| JPWO2022221227A5 (enExample) | ||
| MX2022006104A (es) | Composicion farmaceutica oral que comprende compuesto de carbamato y metodo de preparacion para la misma. | |
| JP2009536665A5 (enExample) | ||
| JP2008509210A5 (enExample) | ||
| US20200046674A1 (en) | Aminocarbonylcarbamate compounds | |
| JP2019085364A5 (enExample) | ||
| JP2021091670A5 (enExample) | ||
| EP4414355A3 (en) | Synthetic retinoids for use in rar activation | |
| JP2003246730A5 (enExample) | ||
| RU2003126176A (ru) | Кислотно-аддитивные соли тербинафина и яблочной кислоты | |
| MX2020009287A (es) | Nuevo compuesto y composicion farmaceutica que lo comprende. | |
| JP2021503010A5 (enExample) |